Utah Medical Products, Inc. announced that its Board of Directors approved a quarterly cash dividend of $0.305 per share of common stock. This dividend is payable on October 2, 2025, to stockholders of record at the close of business on September 17, 2025.
This dividend represents a 1.7% increase over the dividend declared in the same quarter of the prior year. The consistent increase in dividends underscores the company's commitment to returning value to its shareholders.
The declaration of this dividend signals management's confidence in the company's ongoing profitability and strong cash flow generation. It provides a clear financial benefit to stockholders for the upcoming quarter.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.